Medtronic Launches Exchange Offer to Complete MiniMed Separation
MDT sits 27% above its 52-week low of $73.31.
Summary
Medtronic launched an exchange offer to split off at least 80.1% of MiniMed Group, allowing shareholders to exchange Medtronic shares for MiniMed stock at a 7% discount, with the potential to divest Medtronic's entire remaining 90% stake.
Key Events · M&A and Partnerships · MDT
-
Exchange Offer Launched
Medtronic commenced an exchange offer to split off at least 80.1% of MiniMed Group, Inc., allowing shareholders to exchange Medtronic ordinary shares for MiniMed common stock.
-
Exchange Terms
Shareholders receive a 7% discount, with an upper limit of 4.5939 MiniMed shares per Medtronic share. Expected value is $107.53 of MiniMed stock per $100 of Medtronic shares tendered.
-
Minimum Participation Threshold
Completion requires at least 112,680,647 MiniMed shares to be issued in exchange for validly tendered Medtronic shares.
-
Potential Full Divestiture
Medtronic is offering up to 225,361,295 MiniMed shares, with an additional 27,452,053 shares available if oversubscribed, which would divest Medtronic's entire remaining 90% stake.
Analysis · MDT · Industrial Applications And Services
Medtronic is executing the final step of its MiniMed separation, offering shareholders a tax-free exchange of Medtronic shares for MiniMed stock at a 7% discount. This is a major corporate restructuring that will reduce Medtronic's ownership of MiniMed from approximately 90% to potentially zero, unlocking value and allowing Medtronic to focus on its core Cardiovascular, Neuroscience, and Surgical portfolios. The exchange offer is subject to a minimum participation threshold of 112.7 million MiniMed shares, and if fully subscribed, Medtronic will divest its entire remaining stake. The transaction is expected to be generally tax-free for U.S. federal income tax purposes, making it attractive for shareholders. This is a thesis-altering event for both Medtronic and MiniMed shareholders, as it completes the separation of a significant business unit and reshapes Medtronic's capital allocation strategy.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, MDT was trading at $93.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $116.4B. The 52-week trading range was $73.31 to $106.33. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.